Page last updated: 2024-11-08

mitopodozide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mitopodozide: an ethylhydrazide derivative of podophyllic acid; RN given refers to cpd without isomeric designation; [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID251643
CHEMBL ID460289
CHEBI ID135764
SCHEMBL ID745158
MeSH IDM0044145

Synonyms (56)

Synonym
podophyllinsaeure-aethylhydrazid [german]
6qyi7y8obo ,
mitopodozido
mitopodozidum
unii-6qyi7y8obo
(5r,6r,7r,8r)-n'-ethyl-8-hydroxy-7-(hydroxymethyl)-5-[3,4,5-tris(methyloxy)phenyl]-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxole-6-carbohydrazide
naphtho(2,3-d)-1,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide, (5r-(5alpha,6alpha,7beta,8alpha))-
mitopodozide [inn:ban]
mitopodozido [inn-spanish]
einecs 216-138-1
n'-ethylpodophyllohydrazid
ai3-51435
podophyllic acid ethylhydrazide
podophyllinic acid ethylhydrazide
nsc 72274
mitopodozidum [inn-latin]
nsc-72274
sp-i, pharmaceutical
sp-i sandoz
mitopodozide
sp i
naphtho[2,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide
spi-77
podophyllic acid, 2-ethyl-hydrazide
podophyllic acid 2-ethylhydrazide
ind 379
proresid
sp-i (pharmaceutical)
naphtho[2,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide, [5r-(5.alpha.,6.alpha.,7.beta.,8.alpha.)]-
podophyllic acid, ethylhydrazide
podophyllinic acid, 2-ethylhydrazide
proresipar
proreside
nsc72274
podophyllic acid, 2-ethylhydrazide
spi 77
podophyllinsaeure-aethylhydrazid
sp-i
podophyllinic acid 2-ethylhydrazide
sp1 77
sp-i 77
sp 1
sp i sandoz
1508-45-8
CHEBI:135764
1904-80-9
CHEMBL460289
(5r,6r,7r,8r)-n'-ethyl-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxole-6-carbohydrazide
mitopodozide [who-dd]
mitopodozide [inn]
SCHEMBL745158
DTXSID9021211
mitopodozid
naphtho(2,3-d)-1,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide, (5r-(5alpha,6alpha,7beta,8alpha))- (9ci)
Q27265355
AKOS040753075

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" It was not correlated to dosage or duration of either therapy."( Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold.
Bendix, G; Bjelle, A; Holmberg, E, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (27.69)18.7374
1990's25 (38.46)18.2507
2000's22 (33.85)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.17 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.03%)5.53%
Reviews0 (0.00%)6.00%
Case Studies4 (6.06%)4.05%
Observational0 (0.00%)0.25%
Other60 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]